EN PL
 
EN PL
Current issue
Archive
Online first
About the Journal
Instructions for authors
Books and Events
6/2013 vol. 51
Get citation
REVIEW PAPER
Macrophage activation syndrome
Bożena Rojek-Margas
,
 
Beata Śliwowska
,
 
Jolanta Bucka
 
 
 
More details
Hide details
 
Submission date: 2013-07-06
 
 
Final revision date: 2013-09-02
 
 
Acceptance date: 2013-11-18
 
 
Online publication date: 2013-12-24
 
 
Publication date: 2013-12-20
 
 
Reumatologia 2013;51(6):459-466
DOI: https://doi.org/10.5114/reum.2013.39666
 
 
Article (PDF)
References (28)
 
KEYWORDS
macrophage activation syndrome
hemophagocytic syndrome
hemophagocytic lymphohistiocytosis
 
TOPICS
Cytokines, Inflammatory mediators and adaptive immunity in rheumatic diseases
Rheumatoid arthritis- aetiology, pathogenesis, clinical features and treatment
Infection related rheumatoid diseases
 
ABSTRACT
Macrophage activation syndrome (MAS) is a severe complication of systemic connective tissue diseases, particularly systemic juvenile idiopathic arthritis, systemic lupus erythematosus and adult-onset Still’s disease. It is a life-threatening disorder arising from immunoregulation inherited or acquired dysfunction of the NK cells and cytotoxic T-lymphocytes. It is characterized by multi-organ failure with a number of clinical symptoms. So far, there is no standard procedure for treatment. Glucocorticoids, intravenous immunoglobulin, sometimes cyclosporine A and etoposide are used.
REFERENCES (28)
1.
Kelly A, Ramanan AV. Recognition and management of macrophage activation syndrome in juvenile arthritis. Curr Opin Rheumatol 2007; 19: 477-481.
Google Scholar
 
 
2.
Henter J-I. HLH-2004 protocol [Internet]. Histiocyte Society; 2004. Available from: www.histio.org/society/protocols.
Google Scholar
 
 
3.
Klaudel-Dreszler M, Rutynowska-Pronicka O, Gietka P i wsp. Propozycja standardu diagnostyczno-terapeutycznego dla dzieci z podejrzeniem pierwotnego lub wtórnego zespołu hemofagocytarnego w oparciu o doświadczenia Instytutu „Pomnik – Centrum Zdrowia Dziecka” w Warszawie. Standardy medyczne. Pediatria 2010; 7: 194-205.
Google Scholar
 
 
4.
Zoń-Giebel A, Giebel S. Zespół aktywacji makrofagów – reaktywna postać limfohistiocytozy hemofagocytarnej. Reumatologia 2008; 46: 21-26.
Google Scholar
 
 
5.
Ravelli A, Grom AA, Behrens EM, et al. Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: diagnosis, genetics, pathophysiology and treatment. Genes Immun 2012; 13: 289-298.
Google Scholar
 
 
6.
Filipovich AH. Hemophagocytic lymphohistiocytosis (HLH) and related disorders. Hematology Am Soc Hematol Educ Program 2009: 127-131.
Google Scholar
 
 
7.
Machaczka M. Hemophagocytic lymphohistiocytosis – a contemporary medical problem. Pol Merkur Lek 2012; 32: 59-63.
Google Scholar
 
 
8.
Larroche C. Hemophagocytic lymphohistiocytosis in adults: diagnosis and treatment. Joint Bone Spine 2012; 79: 356-361.
Google Scholar
 
 
9.
Usmani GN, Woda BA, Newburger PE. Advances in understanding the pathogenesis of HLH. Br J Haematol 2013; 161: 609-622.
Google Scholar
 
 
10.
Maakaroun NR, Moanna A, Jacob JT, et al. Viral infections associated with haemophagocytic syndrome. Rev Med Virol 2010; 20: 93-105.
Google Scholar
 
 
11.
Jayakar BA, Hashkes PJ. Macrophage activation syndrome: why and what should a gastroenterologist know. J Clin Gastroenterol 2011; 45: 210-214.
Google Scholar
 
 
12.
Deane S, Selmi C, Teuber SS, et al. Macrophage activation syndrome in autoimmune disease. Int Arch Allergy Immunol 2010; 153: 109-120.
Google Scholar
 
 
13.
Jordan MB, Allen CE, Weitzman S, et al. How I treat hemophagocytic lymphohistiocytosis. Blood 2011; 118: 4041-4052.
Google Scholar
 
 
14.
Lin C-I, Yu H-H, Lee J-H, et al. Clinical analysis of macrophage activation syndrome in pediatric patients with autoimmune diseases. Clin Rheumatol 2012; 31: 1223-1230.
Google Scholar
 
 
15.
Pringe A, Trail L, Ruperto N, et al. Macrophage activation syndrome in juvenile systemic lupus erythematosus: an under-recognized complication? Lupus 2007; 16: 587-592.
Google Scholar
 
 
16.
Parodi A, Davì S, Pringe AB, et al. Macrophage activation syndrome in juvenile systemic lupus erythematosus: a multinational multicenter study of thirty-eight patients. Arthritis Rheum 2009; 60: 3388-3399.
Google Scholar
 
 
17.
Tristano AG. Macrophage activation syndrome: a frequent but under-diagnosed complication associated with rheumatic diseases. Med Sci Monit 2008; 14: RA27-RA36.
Google Scholar
 
 
18.
Vilaiyuk S, Sirachainan N, Wanitkun S, et al. Recurrent macrophage activation syndrome as the primary manifestation in systemic lupus erythematosus and the benefit of serial ferritin measurements: a case-based review. Clin Rheumatol 2013; 32: 899-904.
Google Scholar
 
 
19.
Jędrzejczak WW. Limfohistiocytoza hemofagocytarna – rzadko rozpoznawany uleczalny stan bezpośredniego zagrozenia zycia występujący równiez u dorosłych. Acta Haematol Polonica 2008; 39: 515-526.
Google Scholar
 
 
20.
Gietka P, Wieteska-Klimczak A, Smorczewska-Kiljan A i wsp. Reaktywne zespoły hemofagocytarne u dzieci z chorobami reumatycznymi. Reumatologia 2011; 49: 96-107.
Google Scholar
 
 
21.
Gupta AA, Tyrrell P, Valani R, et al. Experience with hemophagocytic lymphohistiocytosis/macrophage activation syndrome at a single institution. J Pediatr Hematol Oncol 2009; 31: 81-84.
Google Scholar
 
 
22.
Lehmberg K, Pink I, Eulenburg C, et al. Differentiating macrophage activation syndrome in systemic juvenile idiopathic arthritis from other forms of hemophagocytic lymphohistiocytosis. J Pediatr 2013; 162: 1245-1251.
Google Scholar
 
 
23.
Bennett TD, Fluchel M, Hersh AO, et al. Macrophage activation syndrome in children with systemic lupus erythematosus and children with juvenile idiopathic arthritis. Arthritis Rheum 2012; 64: 4135-4142.
Google Scholar
 
 
24.
Janka GE. Hemophagocytic syndromes. Blood Rev 2007; 21: 245-253.
Google Scholar
 
 
25.
Bustos B R, Carrasco A C, Toledo R C. Plasmapheresis for macrophage activation syndrome and multiorgan failure as first presentation of juvenile dermatomyositis. Ann Pediatr (Barc) 2012; 77: 47-50.
Google Scholar
 
 
26.
Kelly A, Ramanan AV. A case of macrophage activation syndrome successfully treated with anakinra. Nat Clin Pract Rheumatol 2008; 4: 615-620.
Google Scholar
 
 
27.
Loh NK, Lucas M, Fernandez S, et al. Successful treatment of macrophage activation syndrome complicating adult Still disease with anakinra. Intern Med J 2012; 42: 1358-1362.
Google Scholar
 
 
28.
De Boysson H, Février J, Nicolle A, et al. Tocilizumab in the treatment of the adult-onset Still’s disease: current clinical evidence. Clin Rheumatol 2013; 32: 141-147.
Google Scholar
 
 
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Share
Send by email
RELATED ARTICLE
How to diagnose macrophage activation syndrome early: own experience of the Department of Paediatric Cardiology and Rheumatology in Lodz
Review article
Macrophage activation syndrome – a reactive haemophagocytic lymphohistiocytosis
Reactive hemophagocytic syndromes in children with rheumatic diseases
A fine line between macrophage activation syndrome and multisystem inflammatory syndrome in children – literature review based on two case reports
Clinical variability of the systemic juvenile idiopathic arthritis course: literature review based on case series
Indexes
 
Keywords index
Topics index
Authors index
eISSN:2084-9834
ISSN:0034-6233
Journals System - logo
© 2006-2024 Journal hosting platform by Bentus
Scroll to top